Charu C Garg
Biographic Data
| ID | 7498622 |
|---|---|
| NAME | Charu C Garg |
| GIVEN NAMES | Charu C |
| FAMILY NAME | Garg |
| SIGNATURE | GARG C C |
| AFFILIATIONS | World Health Organization |
| ORCID | 0000-0002-7263-7647 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 18 |
| WORKS AS AUTHOR | 11 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Evaluating the cost-effectiveness of new treatment strategies for the management of young infants with low- or moderate-mortality risk signs of possible serious bacterial infection
Background: The World Health Organization (WHO) is coordinating two randomised controlled trials (RCTs) across three sites in Africa (Ethiopia, Nigeria, and Tanzania) and four in Asia (one in Bangladesh, two in India, and one in Pakistan) to generate evidence on the optimal place of treatment for young infants (YIs) with a single low-mortality risk sign of possible serious bacterial infection (PSBI) and switching antibiotic therapy from injectabl…
Cost of treating sick young infants (0-59 days) with Possible Serious Bacterial Infection in resource-constrained outpatient primary care facilities
Background: Information on the average and incremental costs of implementing alternative strategies for treating young infants 0-59 days old in primary health facilities with signs of possible serious bacterial infection (PSBI) when a referral is not feasible is limited but valuable for policymakers. Methods: Direct activity costs were calculated for outpatient treatment of PSBI and pneumonia in two districts of India: Palwal, Haryana and Lucknow…
A comparison of the cost of outpatient care delivered by Aam Aadmi Mohalla Clinics compared to other public and private facilities in Delhi, India
Aam Admi Mohalla Clinics (AAMCs) were introduced in Delhi in 2015 as neighbourhood clinics to strengthen the delivery of primary care. To inform the policies on government investments for outpatient care, this study estimated the cost of outpatient care per visit in Delhi for 2019–20 for AAMCs and compared it with urban primary health centres (UPHCs), public hospitals, private clinics and private hospitals. Facility costs for AAMCs and UPHCs were…
Out-of-pocket Expenditure on Medicines and Financial Risk Protection in India
Out-of-pocket expenditures on medicines (ME) form a large share of the total out-of-pocket expenditure (OOPE) and pose financial risks for Indian households. Using repeated cross-section analysis of national health surveys for 2014 and 2017–2018, change in financial risk due to ME is examined. Logit regression is used to look at the factors associated with financial risk due to medicine expenditure. Households incurring ME declined by 7%. Per cap…
Methods and Measurement of Primary, Secondary and Tertiary Healthcare Expenditures in India During 2013–2014 to 2016–2017
Improving investments in primary health care has become a mounting priority in the context of Universal Health Coverage and India’s National Health Policy 2017 goal to provide cost-effective care. The paper uses the India National Health Accounts, health care providers and health care functions classifications, to allocate current health expenditures (CHE) to primary, secondary and tertiary (PST) care and analyse the trends and composition of PST…
Impoverishment Due to Out-of-pocket Health Expenditures
Various estimates of impoverishment on account of out-of-pocket expenditure (OOPE) on health are available for India, covering different time periods, but there is a void in terms of comparable estimates. This article uses national level surveys conducted by National Sample Survey Organization for measurement of living standards (Consumption Expenditure Survey [CES]) for 2004–2005 and 2011–2012 and Health and Morbidity Survey (HMS) for 2004 and 2…
Reducing out-of-pocket expenditures to reduce poverty
Out-of-pocket (OOP) expenditure on health care has significant implications for poverty in many developing countries. This paper aims to assess the differential impact of OOP expenditure and its components, such as expenditure on inpatient care, outpatient care and on drugs, across different income quintiles, between developed and less developed regions in India. It also attempts to measure poverty at disaggregated rural-urban and state levels. B…
Who pays for health care in Asia?
Catastrophic payments for health care in Asia
Out‐of‐pocket (OOP) payments are the principal means of financing health care throughout much of Asia. We estimate the magnitude and distribution of OOP payments for health care in fourteen countries and territories accounting for 81% of the Asian population. We focus on payments that are catastrophic, in the sense of severely disrupting household living standards, and approximate such payments by those absorbing a large fraction of household res…
The Incidence of Public Spending on Healthcare
The article compares the incidence of public healthcare across 11 Asian countries and provinces, testing the dominance of healthcare concentration curves against an equal distribution and Lorenz curves and across countries. The analysis reveals that the distribution of public healthcare is prorich in most developing countries. That distribution is avoidable, but a propoor incidence is easier to realize at higher national incomes. The experiences …
Effect of payments for health care on poverty estimates in 11 countries in Asia
Reducing out-of-pocket expenditures to reduce poverty
Out-of-pocket (OOP) expenditure on health care has significant implications for poverty in many developing countries. This paper aims to assess the differential impact of OOP expenditure and its components, such as expenditure on inpatient care, outpatient care and on drugs, across different income quintiles, between developed and less developed regions in India. It also attempts to measure poverty at disaggregated rural-urban and state levels. B…
Effect of payments for health care on poverty estimates in 11 countries in Asia
Catastrophic payments for health care in Asia
Out‐of‐pocket (OOP) payments are the principal means of financing health care throughout much of Asia. We estimate the magnitude and distribution of OOP payments for health care in fourteen countries and territories accounting for 81% of the Asian population. We focus on payments that are catastrophic, in the sense of severely disrupting household living standards, and approximate such payments by those absorbing a large fraction of household res…
The Incidence of Public Spending on Healthcare
The article compares the incidence of public healthcare across 11 Asian countries and provinces, testing the dominance of healthcare concentration curves against an equal distribution and Lorenz curves and across countries. The analysis reveals that the distribution of public healthcare is prorich in most developing countries. That distribution is avoidable, but a propoor incidence is easier to realize at higher national incomes. The experiences …
Who pays for health care in Asia?
Reducing out-of-pocket expenditures to reduce poverty
Out-of-pocket (OOP) expenditure on health care has significant implications for poverty in many developing countries. This paper aims to assess the differential impact of OOP expenditure and its components, such as expenditure on inpatient care, outpatient care and on drugs, across different income quintiles, between developed and less developed regions in India. It also attempts to measure poverty at disaggregated rural-urban and state levels. B…
Impoverishment Due to Out-of-pocket Health Expenditures
Various estimates of impoverishment on account of out-of-pocket expenditure (OOPE) on health are available for India, covering different time periods, but there is a void in terms of comparable estimates. This article uses national level surveys conducted by National Sample Survey Organization for measurement of living standards (Consumption Expenditure Survey [CES]) for 2004–2005 and 2011–2012 and Health and Morbidity Survey (HMS) for 2004 and 2…
Methods and Measurement of Primary, Secondary and Tertiary Healthcare Expenditures in India During 2013–2014 to 2016–2017
Improving investments in primary health care has become a mounting priority in the context of Universal Health Coverage and India’s National Health Policy 2017 goal to provide cost-effective care. The paper uses the India National Health Accounts, health care providers and health care functions classifications, to allocate current health expenditures (CHE) to primary, secondary and tertiary (PST) care and analyse the trends and composition of PST…
Cost of treating sick young infants (0-59 days) with Possible Serious Bacterial Infection in resource-constrained outpatient primary care facilities
Background: Information on the average and incremental costs of implementing alternative strategies for treating young infants 0-59 days old in primary health facilities with signs of possible serious bacterial infection (PSBI) when a referral is not feasible is limited but valuable for policymakers. Methods: Direct activity costs were calculated for outpatient treatment of PSBI and pneumonia in two districts of India: Palwal, Haryana and Lucknow…
A comparison of the cost of outpatient care delivered by Aam Aadmi Mohalla Clinics compared to other public and private facilities in Delhi, India
Aam Admi Mohalla Clinics (AAMCs) were introduced in Delhi in 2015 as neighbourhood clinics to strengthen the delivery of primary care. To inform the policies on government investments for outpatient care, this study estimated the cost of outpatient care per visit in Delhi for 2019–20 for AAMCs and compared it with urban primary health centres (UPHCs), public hospitals, private clinics and private hospitals. Facility costs for AAMCs and UPHCs were…
Out-of-pocket Expenditure on Medicines and Financial Risk Protection in India
Out-of-pocket expenditures on medicines (ME) form a large share of the total out-of-pocket expenditure (OOPE) and pose financial risks for Indian households. Using repeated cross-section analysis of national health surveys for 2014 and 2017–2018, change in financial risk due to ME is examined. Logit regression is used to look at the factors associated with financial risk due to medicine expenditure. Households incurring ME declined by 7%. Per cap…
Evaluating the cost-effectiveness of new treatment strategies for the management of young infants with low- or moderate-mortality risk signs of possible serious bacterial infection
Background: The World Health Organization (WHO) is coordinating two randomised controlled trials (RCTs) across three sites in Africa (Ethiopia, Nigeria, and Tanzania) and four in Asia (one in Bangladesh, two in India, and one in Pakistan) to generate evidence on the optimal place of treatment for young infants (YIs) with a single low-mortality risk sign of possible serious bacterial infection (PSBI) and switching antibiotic therapy from injectabl…
Business (9 works) · Health care (9 works) · Healthcare Systems and Reforms (9 works) · Medicine (9 works) · Economic growth (8 works) · Economics (8 works) · Global Health Care Issues (8 works) · Global Maternal and Child Health (8 works) · Environmental health (7 works) · Population (5 works)